PPT-Clostridium difficile Infection (CDI) Prevention Primer

Last reviewed 03042016 Disclaimer The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. (CDI). . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Draft - 12/23/09 --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. Clostridium difficile . Infection (CDI). for Healthcare Providers. HAI Prevention Strategies Subcommittee. August 2011. These presentation slide sets were developed by the Prevention Strategies Subcommittee of the Arizona Healthcare-Associated Infection (HAI) Advisory Committee. Their works was guided by the best available evidence at the time this document was created. The objectives of the PSS are directed at providing access to additional resources for healthcare facilities, creating a repository of informational anc constructing a toolkit of strategies to assist facilities in preventing healthcare-associated infections.. Clostridium . difficile. Infection (CDI). for Non-Clinical . Healthcare Workers. HAI Prevention Strategies Subcommittee. August 2011. These presentation slide sets were developed by the Prevention Strategies Subcommittee of the Arizona Healthcare-Associated Infection (HAI) Advisory Committee. Their works was guided by the best available evidence at the time this document was created. The objectives of the PSS are directed at providing access to additional resources for healthcare facilities, creating a repository of informational anc constructing a toolkit of strategies to assist facilities in preventing healthcare-associated infections.. (CDI). . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Last reviewed . - . 2/29/12 . --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. . Infections Toolkit. . Activity C: ELC Prevention Collaboratives. Last reviewed . - . 2/29/12 . --- Disclaimer: The findings and conclusions in this presentation are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. UC Irvine Medical Center. Department of Internal Medicine. 05/2018. Mitch Edwards, D.O.. Objectives. Define the severity of Clostridium Difficile Infection (CDI). Learn how to treat CDI by degree of severity. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. Kevin W. Garey, PharmD. , MS, FASHP. Professor and Chair. Department . of Pharmacy Practice and Translational Research. Update on progress of city-wide stewardship projects. Focus on a better understanding of antimicrobial resistance in the Houston area. Emerging CDI Trends in 2015: CDI Survey Findings and Tips to Elevate Physician Engagement John Zelem, MD, FACS, Vice President, Clinical & Regulatory Learning Objectives What are documentation basics for physicians? Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH Associate Professor of Medicine Washington University School of Medicine infection (CDI) has become the most common cause of health-care associated infections in the United States.. The Centers for Disease Control and Prevention (CDC) classified . C. difficile. as an immediate public health threat that requires urgent and aggressive action . Michael Gavin MD. Division of Gastroenterology. University of New Mexico. Burden of . Clostridium difficile . Infection. in the United . States. n . engl. j med 372;9 nejm.org . february. 26, 2015. ASSESSMENT INTERVENTION Stop laxative ( if applicable ) and reassess in 24 hours for clinical response prior to ordering C . difficile testing ● Enter order for a single unformed 3 stool sp